{"id":"trimetaphan","brandName":"trimetaphan","genericName":"trimetaphan","companyId":"unknown","companyName":"","phase":"unknown","status":"active","modality":"","aliases":[],"developmentCodes":[],"firstApprovalDate":null,"firstApprovalCountry":null,"aiSummary":"","enrichmentLevel":3,"visitCount":0,"mechanism":{"target":"Neuronal acetylcholine receptor subunit alpha-10, Neuronal acetylcholine receptor subunit alpha-7, Neuronal acetylcholine receptor; alpha3/beta4"},"administration":{},"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":["NCT03028571","NCT00580957","NCT02726711","NCT02425566","NCT00178919","NCT00580619","NCT00179023","NCT01122407","NCT01137253","NCT02245230"],"indications":{"approved":[{"name":"Controlled Hypotension","diseaseId":"controlled-hypotension","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Hypertensive Emergencies","diseaseId":"hypertensive-emergencies","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pulmonary edema","diseaseId":"pulmonary-edema","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"commercial":null,"patents":[],"timeline":[],"rwe":[],"competitors":[],"ownershipHistory":[],"trialDetails":[{"nctId":"NCT03028571","phase":"Phase 1","title":"Acute Sympathetic Blockade and Endogenous Glucose Production","status":"WITHDRAWN","sponsor":"Vanderbilt University Medical Center","isPivotal":false,"enrollment":0,"indication":"Insulin Resistance","completionDate":"2024-12-31"},{"nctId":"NCT00580957","phase":"NA","title":"The Autonomic Nervous System and the Metabolic Syndrome","status":"COMPLETED","sponsor":"Vanderbilt University","isPivotal":false,"enrollment":56,"indication":"Obesity","completionDate":"2015-05"},{"nctId":"NCT02726711","phase":"Phase 1","title":"Reduction in Splanchnic Capacitance Contributes to Sympathetically Dependent Hypertension in Autonomic Aim 1 of Rare Diseases Clinical Research Network (RDCRN) Project 2","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University","isPivotal":false,"enrollment":2,"indication":"Multiple System Atrophy, Orthostatic Hypotension","completionDate":"2026-12"},{"nctId":"NCT02425566","phase":"Phase 1","title":"Role of Sympathetic Activity and Splanchnic Capacitance in Hypertension","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University","isPivotal":false,"enrollment":12,"indication":"Hypertension","completionDate":"2026-08"},{"nctId":"NCT00178919","phase":"NA","title":"Cardiovascular Regulation: Autonomic/Metabolic Mechanisms PO1 HL56693, Project 4: Cardiovascular Regulation: Autonomic/Metabolic Mechanisms","status":"COMPLETED","sponsor":"Vanderbilt University","isPivotal":false,"enrollment":112,"indication":"Hypertension, Pure Autonomic Failure","completionDate":"2008-08"},{"nctId":"NCT00580619","phase":"Phase 1","title":"Autonomic Nervous System and Chronic Fatigue Syndrome","status":"COMPLETED","sponsor":"Vanderbilt University","isPivotal":false,"enrollment":170,"indication":"Chronic Fatigue Syndrome, Orthostatic Intolerance","completionDate":"2017-01"},{"nctId":"NCT00179023","phase":"Phase 1","title":"The Autonomic Nervous System and Obesity","status":"COMPLETED","sponsor":"Vanderbilt University","isPivotal":false,"enrollment":128,"indication":"OBESITY, HYPERTENSION","completionDate":"2017-01"},{"nctId":"NCT01122407","phase":"Phase 1","title":"Obesity, Hypertension in African American Women, Neuro-metabolic Mechanism","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","isPivotal":false,"enrollment":34,"indication":"Obesity, Hypertension","completionDate":"2016-11"},{"nctId":"NCT01137253","phase":"Phase 1","title":"The Autonomic Nervous System, Nitric Oxide and TPA Interactions","status":"COMPLETED","sponsor":"Vanderbilt University","isPivotal":false,"enrollment":21,"indication":"Endothelial Dysfunction","completionDate":"2017-01"},{"nctId":"NCT02245230","phase":"Phase 1","title":"Cardiovascular Effects of Angiotensin (1-7) in Essential Hypertension","status":"TERMINATED","sponsor":"Vanderbilt University","isPivotal":false,"enrollment":24,"indication":"Hypertension, Hypertension, Essential","completionDate":"2023-12"}],"genericFilers":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"labelChanges":[],"nice":null,"revenue":null,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}